Coastal Corporation Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
COASTCORP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.7 pts more than Nifty Microcap 250 and 3.7 pts more than its Food Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Coastal Corporation reported Q3 FY26 results (quarter ended Dec 31, 2025) with strong consolidated growth driven by subsidiary operations. Consolidated revenue rose to ~Rs 308 cr in Q3 (up ~65% YoY) and ~Rs 659 cr for 9M FY26 (up ~38% YoY), with PAT at ~Rs 7.09 cr (Q3) and ~Rs 16.51 cr (9M FY26), boosted by Coastal Biotech's ethanol sales to Oil Marketing Companies and Continental Fisheries. On a standalone basis, revenue grew ~6% YoY to ~Rs 195 cr but PAT declined ~32% to Rs 3.16 cr due to higher input and operating costs. The statutory auditor flagged an emphasis of matter/qualification on non-provision of Rs 25 cr impairment on Seacrest Seafoods Inc. (US subsidiary with negative net worth), stating they were 'unable to express an opinion' on the matter. FPPCA power charges of ~Rs 1.83 cr (FY23 and FY24) are disclosed as contingent liabilities under appeal before APTEL. The Rs 42.4 cr Rights Issue proceeds show no deviation from stated objects, fully utilized for ethanol and shrimp processing capacities.
Consolidated numbers look strong on the back of subsidiary ramp-up, but standalone profitability is under pressure and the auditor's qualification on the Rs 25 cr Seacrest exposure is a key risk to monitor. The stock may react positively to consolidated growth, but the impairment overhang and FPPCA appeals cap upside until clarity emerges.